In millions, except per share items | Apr-30-21 | Jan-31-21 | Oct-31-20 | Jul-31-20 | Apr-30-20 | Jan-31-20 | Oct-31-19 | Jul-31-19 |
| 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K |
CASH FLOWS FROM OPERATING ACTIVITIES | | | | | | | | |
Net (Loss) Income | 8.5 | -24.4 | -11.0 | -11.9 | -5.8 | -7.3 | -9.3 | -5.3 |
|
Adjustments to reconcile net (loss) income to net cash used in operating activities: | | | | | | | | |
Depreciation and amortization | 0.3 | 0.3 | 0.3 | 0.2 | 0.2 | 0.2 | 0.2 | -0.1 |
Amortization of operating lease right-of-use assets | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | |
Stock compensation expense | 0.4 | 0.5 | 1.2 | 0.4 | 0.4 | 0.4 | 0.8 | 1.5 |
Shares issued for services | | 0.0 | | 0.0 | 0.1 | 0.2 | | |
Loss of disposal of fixed assets | | | 0.0 | 0.0 | 0.2 | | | |
Amortization of debt discount | 0.6 | 0.2 | 0.2 | 0.6 | 0.8 | 0.9 | 2.1 | 2.0 |
Gain on settlement of accrued interest | -0.4 | | | | | | | |
Gain on forgiveness of PPP loan | -0.1 | | | | | | | |
Change in fair value of derivative liabilities - convertible notes | -0.5 | 0.0 | 0.1 | -0.3 | 0.8 | -0.7 | -0.7 | |
Change in fair value of derivative liabilities - warrants | -3.7 | | | | 0.0 | | | |
Change in fair value of derivative liabilities - downside protection | | | | | -0.2 | 2.0 | 3.0 | -3.1 |
Bad debt expense | | | | | | | 0.0 | |
Increase in notes payable due to default | | | 0.3 | 0.4 | 0.1 | | | |
Change in fair value of common stock payable | -0.1 | 0.1 | -0.1 | 0.0 | 0.1 | -0.1 | | |
Changes in operating assets and liabilities, net of effect of acquisitions: | | | | | | | | |
Accounts receivable | 0.1 | 0.0 | 0.0 | 0.0 | 0.1 | -0.1 | 0.0 | -1.4 |
Inventory | 0.4 | 0.1 | 0.0 | 0.2 | 0.0 | -0.1 | -0.1 | -0.1 |
Accounts payable and accrued expenses | 2.0 | 5.8 | 9.6 | 3.4 | 1.9 | 1.7 | 2.4 | 2.0 |
Interest payable to foundation | 0.3 | 0.2 | 0.2 | | 0.6 | | | |
Contract liabilities | 4.0 | 3.0 | | | | | | |
Operating lease liabilities | 0.0 | 0.0 | | -0.1 | 0.0 | 0.0 | | |
Other current assets | -0.1 | 0.0 | 0.0 | 0.3 | -0.1 | -0.1 | -0.2 | |
Other assets | | | | 0.0 | 0.0 | 0.0 | | 0.0 |
Net cash used in operating activities | 0.6 | -1.0 | -1.3 | -0.6 | -0.9 | -2.8 | -1.8 | -1.5 |
|
CASH FLOWS FROM INVESTING ACTIVITIES: | | | | | | | | |
Purchase of property and equipment | | | | | | 0.0 | 0.0 | 0.0 |
Cash received in acquisition of a business, net of cash paid | | | | | | | 0.0 | |
Net cash provided by investing activities | | | | | | 0.0 | 0.0 | 0.0 |
|
CASH FLOWS FROM FINANCING ACTIVITIES | | | | | | | | |
Loan (repayments to) and proceeds from related party | 0.0 | | | | 0.0 | | | |
Payment of notes payable | -2.2 | -0.1 | -0.1 | | | | -0.9 | 0.0 |
Proceeds from note payable | 2.1 | | | 0.2 | 1.0 | 2.4 | 3.0 | 0.4 |
Proceeds from issuance of common stock | 0.7 | 0.8 | 2.2 | | | 0.1 | | |
Issuance of common stock in a private placement (PIPE), net of fees | 0.7 | 0.8 | 2.2 | | | 0.1 | | |
Proceeds from exercise of warrants | 0.0 | | 0.0 | | | | | |
Net cash provided by financing activities | 0.5 | 0.7 | 2.2 | 0.2 | 1.0 | 2.5 | 2.0 | 0.4 |
Net increase in cash and cash equivalents | 1.7 | | | | 0.1 | | | |
Cash and cash equivalents, beginning of period | | | 0.0 | | | | 0.3 | |
Cash and cash equivalents, end of period | 1.1 | -0.2 | 0.8 | -0.4 | 0.1 | -0.3 | 0.5 | -1.1 |
|
Supplemental Disclosure of Cash Flow Information | | | | | | | | |
Cash paid for interest | | | 0.1 | | | | 0.0 | |
|
Supplemental Disclosure of Non-Cash Investing and Financing Activities | | | | | | | | |
Reduction of derivative liabilities | 0.0 | 0.0 | 0.5 | 1.6 | 0.8 | 0.4 | 1.9 | |
Issuance of shares--common stock payable | | 1.5 | | | 0.0 | | 0.9 | |
Issuance of common stock for conversion of debt | 0.5 | 0.0 | 1.1 | 0.9 | 1.6 | 1.2 | 1.7 | |
Subscription receivable | | | | | | 0.8 | | |
Shares issued as debt issuance cost | 0.2 | | | | 0.0 | 0.1 | | |
Warrants granted with notes payable | 0.7 | | | | | | | |
Discount on derivative liability upon issuance of debt | | -1.5 | 1.5 | 0.1 | 0.3 | 0.5 | 1.1 | |
Settlement of subsidiary's debt with issuance of stock | | | | | 0.0 | | | |
Issuance of common stock and warrants from PIPE offering | 21.6 | | | | | | | |
Elimination of derivative liability from exercise of warrants | | 1.8 | | | | | | |